174 related articles for article (PubMed ID: 9703591)
1. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients.
Scharf MB; Lai AA; Branigan B; Stover R; Berkowitz DB
Sleep; 1998 Aug; 21(5):507-14. PubMed ID: 9703591
[TBL] [Abstract][Full Text] [Related]
2. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Bogan RK; Roth T; Schwartz J; Miloslavsky M
J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
[TBL] [Abstract][Full Text] [Related]
3. GHB levels in breast milk of women with narcolepsy with cataplexy treated with sodium oxybate.
Barker EC; Puchowicz M; Letterio J; Higgins K; Sharkey KM
Sleep Med; 2017 Aug; 36():172-177. PubMed ID: 28668666
[TBL] [Abstract][Full Text] [Related]
4. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y
Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895
[TBL] [Abstract][Full Text] [Related]
5. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis.
Xu XM; Wei YD; Liu Y; Li ZX
Sleep Med; 2019 Dec; 64():62-70. PubMed ID: 31671326
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
Xyrem International Study Group
J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
[TBL] [Abstract][Full Text] [Related]
8. Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment.
Tittarelli R; Pichini S; Pedersen DS; Pacifici R; Moresco M; Pizza F; Busardò FP; Plazzi G
Forensic Sci Int; 2017 May; 274():70-74. PubMed ID: 28139340
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.
Borgen LA; Okerholm RA; Lai A; Scharf MB
J Clin Pharmacol; 2004 Mar; 44(3):253-7. PubMed ID: 14973300
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study.
Lecendreux M; Poli F; Oudiette D; Benazzouz F; Donjacour CE; Franceschini C; Finotti E; Pizza F; Bruni O; Plazzi G
Sleep; 2012 May; 35(5):709-11. PubMed ID: 22547897
[TBL] [Abstract][Full Text] [Related]
12. GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy.
Black SW; Morairty SR; Chen TM; Leung AK; Wisor JP; Yamanaka A; Kilduff TS
J Neurosci; 2014 May; 34(19):6485-94. PubMed ID: 24806675
[TBL] [Abstract][Full Text] [Related]
13. Sodium oxybate: a review of its use in the management of narcolepsy.
Robinson DM; Keating GM
CNS Drugs; 2007; 21(4):337-54. PubMed ID: 17381187
[TBL] [Abstract][Full Text] [Related]
14. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.
Scrima L; Hartman PG; Johnson FH; Thomas EE; Hiller FC
Sleep; 1990 Dec; 13(6):479-90. PubMed ID: 2281247
[TBL] [Abstract][Full Text] [Related]
15. Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy.
Moresco M; Pizza F; Antelmi E; Plazzi G
Curr Drug Metab; 2018; 19(13):1073-1079. PubMed ID: 29512449
[TBL] [Abstract][Full Text] [Related]
16. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.
Mamelak M; Scharf MB; Woods M
Sleep; 1986; 9(1 Pt 2):285-9. PubMed ID: 3704454
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.
Scrima L; Hartman PG; Johnson FH; Hiller FC
Biol Psychiatry; 1989 Aug; 26(4):331-43. PubMed ID: 2669980
[TBL] [Abstract][Full Text] [Related]
18. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
[TBL] [Abstract][Full Text] [Related]
19. Determination of GHB and GHB-β-O-glucuronide in hair of three narcoleptic patients-Comparison between single and chronic GHB exposure.
Mehling LM; Wang X; Johansen SS; Spottke A; Heidbreder A; Young P; Madea B; Hess C
Forensic Sci Int; 2017 Sep; 278():e8-e13. PubMed ID: 28811136
[TBL] [Abstract][Full Text] [Related]
20. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
Scharf MB; Brown D; Woods M; Brown L; Hirschowitz J
J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
